ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3450
0.00 (0.00%)
Jul 3, 2026, 3:00 PM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 18.65 million as of July 6, 2026. Its market cap has increased by 7.61% in one year.
Market Cap
18.65M
Enterprise Value
15.92M
Revenue
28.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 18.65M, a decrease of -25.36%. That is a compound annual growth rate of -3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 18.65M | -13.72% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 415.57M |
| Monash IVF Group | 274.69M |
| Healius | 272.30M |
| Cryosite | 61.01M |
| INOVIQ | 35.19M |
| Rhythm Biosciences | 33.97M |
| BCAL Diagnostics | 27.65M |
| Microba Life Sciences | 23.75M |